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Summary 
Substance P  (SP),  a neurotachykinin, is important in a number of inflammatory processes  in 
which the endothelial cell also plays a critical role. SP receptors have previously been identified 
only on arterial endothelium, and the scant in vitro evidence for direct effects of SP on human 
endothelium  is  based  on  studies  using  nonarterial  cells.  To  better  understand  SP's  role  in 
inflammation, we sought to identify functional SP receptors on human endothelium in situ and 
in culture. Autoradiographic ligand binding to human umbilical cord sections demonstrates the 
presence of SP binding sites with characteristics of the neurokinin 1 (NK-1) receptor (displacement 
by GTP analogues and the NK-1 specific antagonist CP-96,345)  on human umbilical arterial, 
but not venous, endothelium. In culture, human umbilical venous endothelial cells (HUVECs) 
and human aortic endothelial cells express low levels of available SP binding sites.  However, 
HUVECs,  which are serum starved and refed, undergo a dramatic increase in SP binding. SP 
binding to starved/refed HUVECs induces a transient increase in intracellular calcium. This calcium 
flux is dose dependent over appropriate SP concentrations and can be blocked by NK-1 specific 
antagonists.  The proinflammatory effects of SP may be mediated in part through the NK-1 receptor 
on endothelium. 
S 
ubstance  P  (SP) 1,  an  11  peptide  neurotachykinin dis- 
covered in 1931 by yon Euler and Gaddum (1), was charac- 
terized originally by its seemingly paradoxical ability to cause 
contraction of intestinal smooth muscle, but relaxation of 
vascular smooth muscle. It has since been shown in vascular 
ring studies that SP causes vascular relaxation through a mech- 
anism consistent with the production of nitric oxide by the 
endothelium (2, 3). In addition, experimental data have im- 
plicated  SP's  participation  in  a  number  of inflammatory 
processes including vascular leak (4), migration and activa- 
tion of white blood cells (5-10), and neovascularization (11), 
all processes in which endothelial interactions are critical. De- 
spite the aforementioned evidence, it is not clear that SP acts 
directly on the vascular endothelium. For example, the wheal 
and flare induced by cutaneous injection of SP is mediated 
in part by release of histamine from mast cells (4). Published 
evidence for a direct effect in vitro  of SP on isolated en- 
dothelium is modest. SP has been reported to act as a growth 
a Abbreviations used in this paper: [Ca2+]i, intracellular  calcium; HAEC, 
human  aortic  endothelial  cell; HUVEC, human  umbilical  venous  endothelial 
cell; NK-1, neurokinin 1;  PPT-SP, (o-pro  2,  o-phe  7,  D-trpg)-sP; SP, 
substance P. 
(11) and chemotactic (12) factor for cultured endothelium. 
Endothelial cultures may also contain monocytes, which have 
been  shown  to  respond  to  SP  by releasing a  number of 
cytokines such as IL-1 (13) which may have paracrine effects 
on endothelial cell function. SP has also been reported to in- 
duce endothelial leukocyte adhesion molecule 1 (ELAM-1) 
in microvascular endothelial cells, and in this case, the induc- 
tion of ELAM-1 was due to mast cell products contaminating 
the experimental culture system (14). 
If SP acts directly on endothelium, it should be possible 
to identify specific, functional receptors on the endothelial 
cell.  SP binding sites have been identified autoradiographi- 
cally on endothelium in situ, generally only in the arterial 
system and with significant interspecies variability (15-17). 
The neurokonin 1 (NK-1) receptor has the highest affinity 
of these binding sites for SP, with an apparent Ka of 10-10 M 
(18). This SP receptor is a member of the G-protein-linked, 
seven transmembrane region family of receptors (19-21).  SP 
also binds, with much lower affinity, to the NK-2 and NK-3 
receptors (the receptors for neurokinins A  and B) (22),  to 
a member of the heat-shock protein 70 family (23), and pos- 
sibly to other unidentified molecules (24). The data presented 
below will demonstrate that a functional NK-l-like receptor 
is present on human vascular endothelium, and that despite 
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functionally active binding of SP to cultured human umbil- 
ical venous endothelial cells (HUVECs) can be induced by 
serum starvation. 
Materials and Methods 
Materials.  Substance  P, (D-pro  2, D-phe  7, D-trpg)-sP (PPT-SP), 
leupeptin, chymostatin, bacitracin, and phosphoramidon were ob- 
tained from Sigma Immunochemicals (St. Louis, MO). ~I-SP (la- 
beled by the Bohon-Hunter method and purified by HPLC to a 
sp act of ~2,000 Ci/mmol; 22) was a gift ofJ. E. Magio (Harvard 
Medical School, Boston, MA); CP-96,345 [(2S,3S)-cis-2-(diphenyl- 
methyl)-N-((2-methoxyphenyl)-methyl)-l-azabicyclo  (2.2.2) octan- 
3-amine] was a gift ofM. Snider (Pfizer, Groton, CT); Indo-l-AM 
was from Molecular Probes, Inc~ (Eugene, OIL); coverglass  chamber 
slides were from Nunc (Napervilh,  IL); M199 with Earles salts 
were from Mediatech (Wash. DC); HBSS, calf and fetal bovine 
serum, ILPMI, t-glutamine, and antibiotics were all obtained from 
Gibco (Grand Island, NY);  IM-9 cells came from the American 
Type Culture Collection (ILockville,  MD); and the Anchored Cell 
Analysis System (ACAS) 570 was from Meridian Instruments, Inc. 
(Okemos,  MI). 
Autoradiography.  Umbilical cords were collected shortly after 
delivery in sterile containers and stored at 4~  until use. 1-2-cm 
segments were frozen, cut into 15-/~m sections, and then thaw- 
mounted onto gelatin-coated slides. The slides were incubated for 
10 rain in a solution of 0.005%  polyethylenimine, and then for 
2 h at room temperature in a 50-mM Tris-buffered solution at pH 
7.4 containing  100 pM t2sI-SP (with or without cold SP or other 
competitive agents as indicated), 2 mg/ml chymostatin, 4 mg/ml 
leupeptin, I mg/ml bacitracin, 0.05% BSA, and 10/~M MnCI (22). 
The slides were then washed in Tris buffer and placed in apposition 
to fl-max hyperfilm for 5-10 d to produce images for analysis. 
Quantitative Binding Assays.  Umbilical venous cells were har- 
vested with collagenase and cultured in M199 with 20% bovine 
serum as previously described (25). Primary cultures were grown 
on 100-mm culture plates and passaged onto 24-well 2 cm  2 plates 
and grown to confluence. Cells used between passages 1-3 were 
identical in SP binding  and contained <1% monocytes. For cell 
starvation experiments, the culture media was changed to 2% bo- 
vine serum while the cells  were subconfhent. These cells  were main- 
tained for at least 48 h in low-serum media, and then refed with 
media containing 20% bovine serum 4 h before experimental ma- 
nipulation. Human aortic endothelial cells (HAECs) were cultured 
as previously described (26). IM-9 cells (a lymphoblastoid cell line 
known to express high levels of NK-1 receptor; 27) were grown 
to a concentration of 10-s-10 -6 cells/ml in RPMI with 15% fetal 
bovine serum. Binding assays were carried out at 4~  for 1 h in 
HBSS with 10 mM Hepes at pH 7.4, 2 mg/ml chymostatin,  4 
mg/ml leupeptin,  I mg/ml bacitracin, 10-s M phosphoramidon, 
0.5% human serum albumin, and varying concentrations of 12sI-SP. 
Nonspecific binding  was determined in the presence of 10 -6 M 
CP-96,345, an NK-1 specific  antagonist (28). Free 12sI-SP concen- 
trations were determined at the end of the experiment by counting 
samples of the cell-free superuatant.  For bound SP, the cell layer 
was washed twice with HBSS, solubilized with 1 N NaOH, and 
counted in the same manner. Binding to IM-9 cells was assayed 
with cells in suspension (106/ml). Free and bound counts were de- 
retrained by pelleting the IM-9 cells  in a microcentrifuge at 10,000g 
for 5 min and counting an aliquot of the superuatant and washed 
cell pellet. For some experiments, to assess ligand degradation, the 
reaction mixture was aspirated at the end of the endothelial binding 
assay, centrifuged,  and the cell-free supernatant  reused to assay 
binding  to IM-9 cells. NK-1 specific binding  was defined as the 
difference in total and nonspecific (CP-96,345 nondisplaceable) 
binding.  At the concentrations of 12sI-SP used, cold SP was only 
slightly more effective  than CP-96,345 at displacing the radioligand 
from endothelial and IM-9 cells. 
Intracellular C,  akium (Ca:+]~  Measurements.  Passaged  endothelial 
cells were grown to confluence on glass coverslip chamber slides, 
and in some experiments, starved/refed as described  above. The cells 
were incubated with 4 mM Indo-1 acetoxymethyl ester (dissolved 
in culture media with 20% serum) for 1 h and then washed and 
covered with HBSS with 0.5% human albumin and 10 mM Hepes 
at pH 7.4. After 1 h (to allow metabolism of Indo-1 to its cell- 
impermeant free acid), the slide was placed on the incubated stage 
of the laser cytometer (model ACAS 570; Meridian Instruments, 
Inc.) (29) and maintained at 37~  throughout the experiment. The 
cell layer was brought into sharp focus under phase-contrast with 
a 100 x  inverted oil-immersion lens. The cells were excited by a 
laser at 360 nm, and fluorescence measured at 480 (free Indo-1) 
and 405 nm (Indo-1 bound to calcium), while aliquots of various 
agonists (dissolved in buffer identical to that which covered the 
cells) were added to the chambers. Cells were scanned by auto- 
mated movement of the stage to produce a two-dimensional image 
of a field of cells every 30 s, or a single line through several cells 
every 0.5 s. Relative calcium values were determined from the ratio 
of  fluorescence  at the two wavelengths, 405/480. To determine ab- 
solute values for intraceUular  calcium  concentration, a standard curve 
was constructed using 4 mM Indo-1 free acid in a high potassium 
buffer [10 mM 3-(N-morpholino)propanesulfonic  acid, 115 mM 
KC1, 20 mM NaCI, I mM EGTA] containing 40% ethanol (30). 
Results 
Autoradiography.  12sI-SP bound  to  frozen  sections  of 
human umbilical cords (Fig.  1). Specific binding,  displace- 
able by excess unlabeled SP, was confined to the luminal sur- 
face of the arteries, and was not seen in the umbilical veins. 
Occasional arteries (arrow in Fig. 1) that showed no specific 
binding were found on histologic examination to have been 
denuded of endothelium. This binding of SP to the arterial 
endothelium was dependent on the concentration of t2sI-SP 
over the range of 10-1,500 pM (data not shown).  At  100 
pM, 12sI-SP binding was inhibited by coincubation with the 
NK-1  specific antagonist  CP-96,345 at a concentration of 
10-6 M, as well as with the nonhydrolyzable GTP analogues 
guanosine 5'-O-(2-thiodiphosphate) (GPS) and 5'-guanyly- 
limidodiphosphate (GPP) (Fig.  2). 
SP Binding to Cultured Endotheliura.  HUVECs, as well as 
HAECs, demonstrated very low levels of specific binding of 
12sI-SP at 150 pM that was displaceable  by CP-96,345 (Fig. 
3). Since the level of specific binding was so low, other cul- 
ture conditions were  evaluated in  an  attempt  to  increase 
receptor expression. When the HUVECs were serum starved 
for 48 h, there was a marked increase in NK-1 specific binding 
(Fig. 3). This binding reached equilibrium by 60 rain (Fig. 
4 a) and was saturable at concentrations (Kay0.6 nM) (Fig. 
4 b) compatible with the reported Kd of 0.1 nM in porcine 
aortic endothelial membranes (18).  To assure  that the low 
level of binding to nonstarved cells was not due to degrada- 
1270  Endothelium  and Substance P Receptors Figure  1.  Representative  autoradiograms  of human umbilical  cords (total n ffi 10). (Left)  Frozen sections of" two cords incubated  with 100 pM 
nsI-SP. (Right)  Serial sections of the same cords incubated under the same conditions  except with the addition of an excess (10 -4 M) of unlabeled 
SP. The white silver grains represent areas of mI-SP binding. Note the intense signal at the luminal surface of the two arteries in each cord which 
is displaced  by cold SP, and the absence of such signal  in the single, large veins. An occasional  artery  (arrow) lacked specific  binding, and such arteries 
were found on histologic staining to have been denuded of endothelium. 
tion of the ligand during incubation with HUVECs, the fol- 
lowing control experiments were carried out with IM-9 cells 
(which are known to express high levels of NK-1 receptor; 
27). Parallel binding experiments on IM-9 cells were performed 
by either reusing the supernatant at  the end of HUVEC 
binding experiments or using fresh nsI-SP dilutions under 
the same conditions. Both gave similar binding curves to IM-9 
cells showing a Ka between 0.2 and 1 nM, with 30,000- 
90,000  sites per cell (n  =  3),  consistent with previous re- 
ports  (27). 
[Ca2+~ Measurements.  To demonstrate that this receptor 
is functionally active, changes in [Ca2+]i in response  to SP 
were examined. HUVECs exposed to SP demonstrated an 
immediate, transient increase in [Ca2+]i, and once a cell had 
responded it would not respond to a higher concentration 
of SP (Fig.  5 a). This response was blocked by CP-96,345 
(vide infla) or the partial agonist PPT-SP, neither of which 
affected the response to unrelated agonists such as thrombin 
(Fig.  5 b) or histamine (data not shown). The number of 
endothelial cells manifesting a rise in [Ca  2+ ]i was dose de- 
pendent over the range of 10-11-10-s  M  SP (Fig.  6).  The 
top right panel of Fig. 6 shows a summary of the calcium 
response of 23 cells in a single representative experiment with 
each vertical line indicating the addition of 1 log higher con- 
centration of SP, from 10-10 to 10-s M. No additional cells 
could be recruited by concentrations >10 -s M, and no cells 
responded in the presence  of 10 -6 M  CP-96,345  (Fig. 7). 
Whereas only 10% of unstarved cells in an experimental field 
responded to maximal concentrations of SP, about 50% of 
starved/refed cells did respond (Fig.  7).  Refeeding alone is 
not effective in increasing responses,  as the protocol for our 
calcium determinations involves exposure of the cells to flesh 
media 2-3 h before the experiment. Conditions of growth 
such as endothelial growth factors, variation in passage number, 
time in culture, or degree of confluence did not influence 
calcium responses  (data not shown).  Unstarved HUVECs 
cultured in the presence  of IL-1/$ or IFN-3,, as well as un- 
starved HAECs (n  =  4 for each group)  all demonstrated 
<10%  of cells responding to SE 
Discussion 
The autoradiograms of human umbilical cords demonstrate 
specific SP binding to the arterial  endothelium, but not to 
1271  Greeno  et al. Figure  2.  Representative  autoradiogram  of one umbilical artery incubated  with: 100 pM 12sI-SP again showing  binding to the luminal surface; 
12sl-SP plus 5'-guanylylimidodiphosphate  (GPP 1 mM); 12sI-SP plus guanosine  5'-O-(2-thiodiphosphate)  (GPS 1 mM); 12sI-SP plus CP-96,345 (1 mM); 
each showing displacement of labeled SP. 
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Figure 3.  Results  of NK-1 specific 12sI-SP binding (150 pM for 1 h) 
to HUVECs (n  =  12), HAECs (n  =  11), and HUVECs after starv- 
ing/refeeding  as described in Materials  and Methods  (n = 5). NK-1 spe- 
cific  binding  is determined  from the difference  in binding  in the presence 
or absence  of the NK-1 specific  inhibitor  CP-96,345. Nonspeciiic  binding 
(in cpm) for each group, respectively,  was 1,916 _+ 172, 1,781 _+ 90, and 
2,433  _+  132. All experiments were conducted  at 4~  in the presence 
of protease inhibitors  as described  in Materials  and Methods. Error bars 
represent the SE of the mean. 
the umbilical vein from which cultured cells are most com- 
monly obtained. These binding sites are G-protein-linked as 
indicated by the displacement by GPS and GPP. These non- 
hydrolyzable GTP analogues presumably block binding of 
SP by disrupting the normal association of the G-protein com- 
plex with the cytoplasmic tail of the receptor,  resulting in 
a conformational change in the receptor's extraceUular  do- 
main (18). The NK-1,  NK-2,  and NK-3 receptors are  all 
G-protein-linked, and all bind SP, but the binding in this 
case was completely blocked by CP-96,345 at 10-6 M. This 
compound, when tested against SP, has a pA2 (the negative 
log of  the half-maximal inhibitory  concentration) for the NK-1 
receptor of 9.5, but only 4.3 and 5.6 for the NK-2 and NK-3 
receptors,  respectively,  so it would not be expected to cause 
complete displacement of SP from NK-2 or NK-3 receptors 
at  the concentration used (31). These data argue that the 
binding sites are the NK-1 receptor. 
Despite the apparent lack of autoradiographically demon- 
st-cable venous binding rites in ritu, cultured venous endothelial 
cells did show specific binding in a pattern consistent with 
the presence  of NK-1  receptors.  The  level of binding to 
HUVECs was very low under standard culture conditions. 
However, binding was much higher in cells that had been 
starved and refed.  In agreement with this observation, the 
number of HUVECs responding to SP with an increase in 
[Ca  2  +  ]i also increased  dramatically after starving/refeeding. 
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Figure  4.  Representative  binding curves of tzsI-SP incubated  with starved/refed  HUVECs. (a) Time course of both total and  specific binding at  100  pM t2sI-SP. (b) Best fit curve of specific binding (determined by subtracting  nonspecific binding in the presence of 10 -6 M CP-%,345)  was generated 
with Sigmaplot  and gave a Kd ,0630 pM with Bm~, ,016,000  molecules per cell. Nonspecific binding represented  ,x,50% of total binding.  All experi- 
ments were conducted at 4~  in the presence of protease  inhibitors.  Error bars  represent  the SE of the mean of triplicate  determinations. 
Fikmre  5.  Changes in intracellular calcium in single HUVECs scanned 
at 0.5-s intervals.  (a) The immediate response of a single cell exposed to 
10-7 M SP at the first vertical line, with a failure to respond  to the sub- 
sequent  addition of 10 .6 M SP at the second line. No response to a se- 
cond addition was seen even after several minutes, and similar results were 
obtained starting with submaximal concentrations of SP. (b) Another single 
cell which underwent a transient  increase in calcium  upon exposure  to 
10-4 M PFI'-SP (a partial  SP antagonist)  at the first line, and then failed 
to respond to 10 -6 M SP added at the second line. The cell was still able 
to respond  to the addition of 0.5  U/ml thrombin at the third line. 
Autoradiographic data imply differential regulation of NK-1 
receptor expression on arterial versus venous endothelium in 
vivo (15-17), but this difference was not apparent either in 
SP binding or cell activation once these cells were in culture. 
Cocks et al. (3) also demonstrated a discordant response be- 
twin in situ and cultured endothelium. These authors showed 
vascular relaxation induced by SP stimulation of arterial en- 
dothelium in situ. However, when the endothelial cells were 
cultured onto beads and stimulated with SP, the eff/uent did 
not induce relaxation of denuded vascular rings, even though 
cultured cells did respond to other activators of nitric oxide 
release  (3).  In addition,  studies that  demonstrated  that  SP 
stimulated endothelial growth of cultured HU-VECs (prob- 
ably via the NK-1 receptor) (11), were carried out in serum- 
free media, thus subjecting the cells to conditions similar to 
our starvation experiments. Whether the results we obtained 
are  due  to  an  actual  change  in  receptor  number  with 
starving/refeeding  or to some change in the availability or 
af~nity of the receptor, cannot be determined from our data 
at  present. 
The data presented indicate that the binding of SP to the 
cultured endothelium results in a cellular response as manifested 
by the increase in [Ca2+]i. The rapid response suggests that 
this is a direct effect rather than a secondary process due to 
activation  of other cells  such as monocytes.  This response 
is mediated by the NK-1 receptor as evidenced by a dose de- 
pendence  over  the  appropriate  concentration  range  and 
blocking of the response by CP-96,345 (which did not affect 
calcium changes induced by other agonists).  The technique 
of individual  cell fluorescence measurements  allowed us to 
see a wide cell-to-cell heterogeneity in responsiveness to SP. 
1273  Greeno et al. Figure  6.  Changes in [CaZ*]i in multiple individual HUVECs scanned at 30-s intervals. The two small panels (top left) show the false-color fluores- 
cent images of the same field of cells in their resting state scanned simultaneously at 480 (free Indo-1) and 405 nm (Indo-1 bound to calcium).  The 
central portion of each cell has been outlined in black and numbered. (Baseline)  [Ca  2  +  ]i of the field of cells. The image was generated by determining 
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Figure  7.  Summary of the calcium response of HUVECs. Data points 
represent the mean percentage of visualized cells which demonstrated a 
detectable increase in [Ca  2+ ]i (always >50 nM) at each concentration of 
added SP, and error bars are the SE of the mean. For starved/refed cells, 
n =  15 experiments with an average of 21 cells per experiment; with CP- 
96,345 (using starved/refed cells) n =  6, average 18 cells per experiment; 
with standard culture conditions n = 38, average  of 11 cells per experiment. 
This  heterogeneity  is  seen  with  other  agonists  such  as 
thrombin or histamine (Greeno, E., unpublished observation). 
One can speculate that this heterogeneity results from a wide 
distribution  of NK-1 receptor numbers amongst individual 
cells that  require  activation of a  fixed number,  as opposed 
to  a  fixed percentage,  of receptors  on  each cell. 
Our data also indicate that the NK-1 receptor undergoes 
homologous desensitization,  since any cell that responds to 
SP is unable to respond again to SP, but still responds to other 
agonists such as thrombin or histamine with an increase in 
[Ca2+]i.  Such  specific  desensitization  to  SP  has  been  ob- 
served previously in vascular relaxation studies (32). This pro- 
cess may occur in a manner analogous to that in other seven- 
transmembrane domain receptors that undergo homologous 
desensitization due to phosphorylation of the cytoplasmic tail, 
since similar phosphorylation sites are present on the NK-1 
receptor  (20). 
In  summary,  we have demonstrated  NK-1  receptors  on 
human  vascular endothelium  in  situ  and in culture.  These 
receptors are functionally active in cultured endothelium, and 
appear to be increased in number and activity in cells that 
have been starved and refed. This culture system should allow 
further  elucidation  of SP's role in  endothelial  function. 
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